Talis Healthcare

What Talis Healthcare does

Talis Healthcare LLC is a private, Houston-headquartered operator of ambulatory infusion and injection therapy centers serving patients with chronic, complex conditions. The company, founded in 2014, runs a network of clinics across Delaware, Maryland, and Texas, with additional reference to Kansas and Wyoming on its digital properties. Its core service is the in-clinic administration of FDA-approved specialty biologics and monoclonal antibodies—including products such as Ocrevus, Rituxan, Stelara, Keytruda, Soliris, Cosentyx, and Tepezza—delivered under infusion-trained advanced practitioner supervision across more than ten therapeutic specialties spanning rheumatology, nephrology, neurology, pulmonology, hematology/oncology, gastroenterology, ophthalmology, infectious disease, immunology, and dermatology.

The business model is professional-services revenue generated by billing third-party payers for infusion chair time and drug administration. Talis accepts all major insurance plans and supplements patient access through co-pay assistance programs, with dedicated patient resource specialists handling benefits verification and prior-authorization. The go-to-market is a provider-referral motion: physicians in target specialties download per-drug referral forms, the Talis team runs benefit and authorization assessment, schedules the infusion, and conducts post-treatment follow-up. There is also a parallel self-referral pathway for patients contacting the company directly. The company lists 11-50 employees and operates no proprietary software platform, app, or AI-driven clinical tools; its technology footprint is limited to a Wix-hosted website, a third-party patient billing portal (patientnotebook.com), and standard corporate social media profiles on LinkedIn, Facebook, and Instagram.

Capital structure is undisclosed: no funding rounds, investors, leadership team, M&A, or restructuring actions are reported in the available data. The company is operating, actively serving patients, and has signaled procurement formalization through a 2026 Supplier Code of Conduct. Pricing is not publicly disclosed and is determined per treatment through insurance adjudication. Customer concentration is by patient rather than by corporate account, with no enterprise payer or health-system anchor visible in the data.

Name

Talis Healthcare

Legal name

Talis Healthcare LLC

Website

https://talishealthcare.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Talis Healthcare LLC is a private, Houston-based operator of ambulatory infusion and injection therapy clinics delivering FDA-approved specialty biologics and monoclonal antibodies to patients with chronic conditions across Delaware, Maryland, and Texas.

Ownership category

akta.pro rank

Product category

Specialty Infusion Therapy Services

NAICS

Ambulatory Health Care Services (621), All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Infusion Therapy Centers (Outpatient) (HLAFABAF)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Outpatient Parenteral Antimicrobial Therapy (OPAT) (HLAKAGAN)

Keywords

• Infusion therapy services
• Specialty biologic medications
• Outpatient infusion centers
• Chronic disease injections
• Monoclonal antibody treatments

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Infusion Treatment Services: Talis Healthcare generates revenue through providing infusion and injection therapy services to patients. The company accepts all major insurance plans and offers co-pay assistance programs to patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Talis Healthcare operates outpatient infusion centers that administer intravenous and injectable specialty biologic medications for patients with chronic conditions. The company delivers over 60 FDA-approved drugs including Actemra, Benlysta, Ocrevus, Cosentyx, Entyvio, Keytruda, Rituxan, Stelara, and others under advanced practitioner supervision across specialties such as rheumatology, neurology, oncology, gastroenterology, and dermatology. Services are billed through major insurance plans with co-pay assistance programs available to patients.

Product overview

Talis Healthcare is an infusion and injection treatment provider offering specialty biologic medications for chronic conditions. The company operates a network of clinic locations across Delaware, Maryland, and Texas, providing treatments across multiple specialties including rheumatology, nephrology, neurology, pulmonology, hematology/oncology, gastroenterology, ophthalmology, infectious disease, immunology, and dermatology. Services include infusion and injection administration under advanced practitioner supervision, benefits verification and authorization assistance, and co-pay assistance programs. The company offers over 60 specialty medications including Actemra, Benlysta, Ocrevus, Cosentyx, Entyvio, Keytruda, Rituxan, Stelara, Skyrizi, and many others for conditions such as chronic inflammatory diseases, neurological disorders, blood disorders, pulmonary conditions, and oncology.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusion Treatments

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Option Care Health: Largest independent provider of home and alternate-site infusion services in the US, operating a national network. Comparable to Talis because it administers the same types of specialty biologic infusions, but at much greater geographic scale and with broader payer and drug-procurement leverage.
• Coram (CVS Health): CVS Health's specialty infusion arm offering home and site-of-care IV therapy across the country. Competes with Talis for the same referring physicians and biologic infusion referrals, particularly for chronic specialty conditions.
• US Oncology Network (McKesson): Large oncology-focused provider network supported by McKesson, including in-office and site-of-care infusion for cancer patients. Comparable to Talis specifically on its hematology/oncology infusion volume.

Direct peers

• KabaFusion: National specialty and home infusion company providing IVIG, biologics, and acute infusion therapies across multiple states. Directly comparable to Talis for site-of-care infusion services and complex specialty drug administration.
• Amerita: Specialty infusion provider operating across multiple states for chronic and acute conditions. Comparable to Talis in delivering high-cost biologic infusions in alternate-site settings under clinical supervision.
• Paragon Healthcare: Multi-site ambulatory infusion provider operating in the southern US with a similar mix of specialty biologics and chronic-condition focus. Comparable to Talis in clinic-based delivery model and therapeutic breadth.
• Soleo Health: Specialty infusion provider focused on complex chronic conditions including autoimmune, neurological, and rare diseases, with multiple ambulatory infusion centers. Closely comparable to Talis in clinical model, therapeutic coverage, and payer-driven revenue model.
• Vital Care Infusion Services: Franchise-based network of ambulatory infusion centers providing biologic and specialty infusion services. Comparable to Talis in operating model (clinic-based infusion suites) and therapeutic breadth.
• Promptcare: Regional specialty infusion and respiratory therapy provider serving patients with complex chronic conditions. Comparable to Talis in offering site-based and home biologic infusion services for autoimmune and rare diseases.
• TwelveStone Health Partners: Multi-site provider of chronic care infusion and injectable therapies with locations across the southeastern US. Comparable to Talis in its chronic-condition infusion focus and multi-clinic delivery model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/100084909581409
• LinkedInlinkedin.com/company/talis-healthcare-llc
• Instagraminstagram.com/talishealthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Talis Healthcare